J. Alan Diehl has been appointed deputy director and chief operating officer of the Case Comprehensive Cancer Center, a collaboration of Case Western Reserve University, Cleveland Clinic and University Hospitals.

This newly created role will provide substantive oversight of the cancer center to pursue its mission to advance cancer research, training, community outreach and local and national impact as a National Cancer Institute (NCI)-designated comprehensive cancer center.

Diehl will work closely with center director Stanton L. Gerson, the Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology, who will assume the role of interim dean of the Case Western Reserve School of Medicine on July 1, while continuing to serve as cancer center director.

Diehl joined Case Western Reserve in 2019 as chair of the School of Medicine’s Department of Biochemistry. He brings decades of leadership experience in NCI-designated cancer centers, first as director of the cancer cell biology program at the Abramson Family Cancer Research Institute at the University of Pennsylvania, and as associate director of basic science at Hollings Cancer Center at the Medical University of South Carolina.

Diehl’s research focuses on the discovery of molecular mechanisms that contribute to uncontrolled cell proliferation and decreased cell death. He serves on multiple external advisory boards for NCI-designated cancer centers.